Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | ExodusPoint Capital Michael Gelband | 0 | $0 | 0% | |
2. | Clearline Capital Marc Majzner | 0 | $0 | 0% | |
3. | D E Shaw D. E. Shaw | 0 | $0 | 0% | |
4. | AQR Capital Management Cliff Asness | 0 | $0 | 0% | |
5. | GLG Partners Noam Gottesman | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.85 | 16,400 | Officer | 646,465 | 2020-11-12 | Filing | |
$2.79 | 130,000 | Officer | 331,434 | 2017-06-09 | Filing | |
$2.03 | 100,000 | Officer | 100,000 | 2016-12-09 | Filing | |
$0.77 | 20,000 | Officer | 20,000 | 2016-03-21 | Filing | |
$0.72 | 50,000 | Director | 88,172 | 2016-03-18 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$4.28 | 50,000 | Director | 224,406 | 2021-03-11 | Filing | |
$5.00 | 241,960 | Officer, Director | 2,204,760 | 2021-02-18 | Filing | |
$5.01 | 17,844 | Officer, Director | 2,446,720 | 2021-02-18 | Filing | |
$5.00 | 232,156 | Officer, Director | 2,464,564 | 2021-02-18 | Filing | |
$4.75 | 5,519 | Officer, Director | 2,446,720 | 2021-02-17 | Filing |